CELL INTELLIGENCE · 肿瘤细胞治疗研究

PRIMMO 试验中接受 PD-1 阻断、放疗和免疫调节治疗的晚期宫颈癌与子宫内膜癌患者循环免疫细胞谱分析

Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation

纵向免疫变化，而非单纯的基线差异，可区分应答者与非应答者。

靶向 TROP2 的共刺激嵌合抗原受体增强表达人乳头瘤病毒 16 型 E7 反应性 T 细胞受体的 NK 细胞的细胞毒性

A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillo

抗 FAP CAR-NK 细胞作为针对宫颈癌和癌相关成纤维细胞的新型靶向治疗

Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.

间皮素在妇科肿瘤中的作用及其在靶向治疗中的意义——综述

The Role of Mesothelin in Gynecological Tumors and Its Significance in Targeted Therapies-A Review.

骨髓间充质干细胞来源外泌体调控宫颈癌球体的放化疗反应

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Modulate Chemoradiotherapy Response in Cervical Cancer Spheroids.

更正：抗间皮素 CAR-NK 细胞作为针对宫颈癌的新型靶向治疗

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

宫颈癌治疗格局的改变者：免疫治疗

The game changer in the cervical cancer therapeutic landscape: immunotherapy.

抗间皮素 CAR-NK 细胞作为宫颈癌的新型靶向治疗

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

γδ T 细胞介导的对患者来源的健康和癌性宫颈类器官的细胞毒性

γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids.

RIG-I 激动剂 M8 在人乳头瘤病毒相关癌症中触发细胞死亡和 NK 细胞活化并增强顺铂细胞毒性

The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytoto